Drug Shortage Report for AURO-PERINDOPRIL
Report ID | 204530 |
Drug Identification Number | 02459817 |
Brand name | AURO-PERINDOPRIL |
Common or Proper name | AURO-PERINDOPRIL |
Company Name | AURO PHARMA INC |
Market Status | MARKETED |
Active Ingredient(s) | PERINDOPRIL ERBUMINE |
Strength(s) | 2MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 3x10 Blst |
ATC code | C09AA |
ATC description | ACE INHIBITORS, PLAIN |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | 2023-09-15 |
Actual start date | 2023-11-15 |
Estimated end date | 2024-07-31 |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2024-06-13 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 3700 STEELES AVENUE WEST, SUITE 402 WOODBRIDGE, ONTARIO CANADA L4L 8K8 |
Company contact information | Anahita Rostami |
Version History
Click on "Compare" below to view the full report history and compare to other versions.